214 related articles for article (PubMed ID: 30029036)
21. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
22. Blue light induced reactive oxygen species from flavin mononucleotide and flavin adenine dinucleotide on lethality of HeLa cells.
Yang MY; Chang CJ; Chen LY
J Photochem Photobiol B; 2017 Aug; 173():325-332. PubMed ID: 28633062
[TBL] [Abstract][Full Text] [Related]
23. Compositional analysis of endogenous porphyrins from Helicobacter pylori.
Battisti A; Morici P; Signore G; Ghetti F; Sgarbossa A
Biophys Chem; 2017 Oct; 229():25-30. PubMed ID: 28648894
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of protoporphyrin IX performance in aqueous solutions for photodynamic therapy.
Homayoni H; Jiang K; Zou X; Hossu M; Rashidi LH; Chen W
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):258-66. PubMed ID: 25636780
[TBL] [Abstract][Full Text] [Related]
25. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
27. Stimulated release of photosensitizers from graft and diblock micelles for photodynamic therapy.
Tsai HC; Tsai CH; Lin SY; Jhang CR; Chiang YS; Hsiue GH
Biomaterials; 2012 Feb; 33(6):1827-37. PubMed ID: 22142770
[TBL] [Abstract][Full Text] [Related]
28. Protoporphyrin IX-loaded magnetoliposomes as a potential drug delivery system for photodynamic therapy: Fabrication, characterization and in vitro study.
Basoglu H; Bilgin MD; Demir MM
Photodiagnosis Photodyn Ther; 2016 Mar; 13():81-90. PubMed ID: 26751701
[TBL] [Abstract][Full Text] [Related]
29. Comparison of protoporphyrin IX produced cell proliferation inhibition between human breast cancer MCF-7 and MDA-MB-231 cells.
Li L; Chen Y; Wang X; Feng X; Wang P; Liu Q
Pharmazie; 2014 Aug; 69(8):621-8. PubMed ID: 25158574
[TBL] [Abstract][Full Text] [Related]
30. The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
Dogra Y; Ferguson DCJ; Dodd NJF; Smerdon GR; Curnow A; Winyard PG
Redox Biol; 2016 Oct; 9():90-99. PubMed ID: 27454766
[TBL] [Abstract][Full Text] [Related]
31. Photolon™ --photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.
Ali-Seyed M; Bhuvaneswari R; Soo KC; Olivo M
Int J Oncol; 2011 Oct; 39(4):821-31. PubMed ID: 21725591
[TBL] [Abstract][Full Text] [Related]
32. Synergistic in vitro photodynamic antimicrobial activity of methylene blue and chitosan against Helicobacter pylori 26695.
Choi SS; Lee HK; Chae HS
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):526-32. PubMed ID: 25174558
[TBL] [Abstract][Full Text] [Related]
33. Protoporphyrin IX induces apoptosis in HeLa cells prior to photodynamic treatment.
Bednarz N; Zawacka-Pankau J; Kowalska A
Pharmacol Rep; 2007; 59(4):474-9. PubMed ID: 17901578
[TBL] [Abstract][Full Text] [Related]
34. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
35. Enhanced cellular uptake of protoporphyrine IX/linolenic acid-conjugated spherical nanohybrids for photodynamic therapy.
Lee HI; Kim YJ
Colloids Surf B Biointerfaces; 2016 Jun; 142():182-191. PubMed ID: 26954084
[TBL] [Abstract][Full Text] [Related]
36. The background and philosophy behind daylight photodynamic therapy.
Wulf HC
G Ital Dermatol Venereol; 2018 Dec; 153(6):776-782. PubMed ID: 29683283
[TBL] [Abstract][Full Text] [Related]
37. Localization-dependent cell-killing effects of protoporphyrin (PPIX)-lipid micelles and liposomes in photodynamic therapy.
Tachikawa S; Sato S; Hazama H; Kaneda Y; Awazu K; Nakamura H
Bioorg Med Chem; 2015 Dec; 23(24):7578-84. PubMed ID: 26602828
[TBL] [Abstract][Full Text] [Related]
38. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
Herceg V; Lange N; Allémann E; Babič A
J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
[TBL] [Abstract][Full Text] [Related]
39. Hydrothermal derived protoporphyrin IX nanoparticles for inactivation and imaging of bacteria strains.
Ning LG; Liu P; Wang B; Li CM; Kang ET; Lu ZS; Hu XF; Xu LQ
J Colloid Interface Sci; 2019 Aug; 549():72-79. PubMed ID: 31022525
[TBL] [Abstract][Full Text] [Related]
40. Mitochondria-Targeting Polyamine-Protoporphyrin Conjugates for Photodynamic Therapy.
Taba F; Onoda A; Hasegawa U; Enoki T; Ooyama Y; Ohshita J; Hayashi T
ChemMedChem; 2018 Jan; 13(1):15-19. PubMed ID: 28961376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
